Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2017

Open Access 01-12-2017 | Erratum

Erratum to: Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference

Authors: Sung Hoon Choi, Jun Yong Park

Published in: Cancer Cell International | Issue 1/2017

Login to get access

Excerpt

After the publication of the original article [1], it was noted that the pre-revision version of this manuscript was mistakenly published. This erratum contains the correct, revised edition of this manuscript. …
Literature
1.
Metadata
Title
Erratum to: Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference
Authors
Sung Hoon Choi
Jun Yong Park
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2017
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-017-0438-2

Other articles of this Issue 1/2017

Cancer Cell International 1/2017 Go to the issue

Primary Research

Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor

Primary Research

miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling

Primary Research

Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma

Primary Research

Identification of genes and pathways potentially related to PHF20 by gene expression profile analysis of glioblastoma U87 cell line

Primary Research

Tumor-infiltrating CD4+ T cells in patients with gastric cancer

Review

Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits